VILDAVAS-M combines Vildagliptin and Metformin for the management of type 2 diabetes mellitus. The combination provides complementary mechanisms of blood sugar control and may be used when Metformin alone does not provide adequate glycaemic control.
Uses of VILDAVAS-M:
- Management of type 2 diabetes mellitus
- Improved glycaemic control through combination therapy
- Helps reduce overall pill burden
- Used as an adjunct to diet and exercise for blood sugar management